September 24, 2016 6:51 PM ET

Healthcare Providers and Services

Company Overview of Fred Hutchinson Cancer Research Center

Company Overview

Fred Hutchinson Cancer Research Center is engaged in the research to prevent, detect, and treat cancer, HIV/AIDS, and other life-threatening diseases. Its activities in the areas of diseases and research cover fundamental research, prevention, early detection, treatment and cures, and survivorship. The company was incorporated in 1971 and is based in Seattle, Washington.

1100 Fairview Avenue North

P.O. Box 19024

Seattle, WA 98109-1024

United States

Founded in 1971





Key Executives for Fred Hutchinson Cancer Research Center

President and Director
Age: 61
Chief Financial Officer and Vice President
Chief Operating Officer and Executive Vice President
Chief Information Officer and Vice President
Vice President and General Counsel
Compensation as of Fiscal Year 2016.

Fred Hutchinson Cancer Research Center Key Developments

Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance Sign Memorandum of Understanding with BC Cancer Agency

On September 20, 2016, The Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance signed a memorandum of understanding with the BC Cancer Agency to work together on accelerating cancer-fighting technologies. The group aims to accelerate discoveries and enhance cancer research performance, expand patient access to clinical trails and provide better training opportunities for young scientists and researchers. The partnership comes as Washington and British Columbia work to develop a cross-border partnership to encourage broader innovation and collaboration on new technologies and life science discoveries.

Fred Hutchinson Cancer Research Center Announces Executive Appointments

Fred Hutchinson Cancer Research Center announced the appointment of Microsoft CEO Satya Nadella to its board of trustees. He is among five new board members at Fred Hutch, a Seattle-based pioneer in advancing groundbreaking research to prevent, diagnose and treat cancer and related diseases. The incoming 2016-17 board members joining Nadella are Bryan White, founder of Sahsen Ventures LLC; Mike Clayville, a vice president at Amazon Web Services, a cloud-computing leader; Carl Behnke, president of REB Enterprises; and Mark Fleischauer, chairman of JH Kelly Holdings, parent of Washington construction firm JH Kelly. In addition, the board designated Jim Sinegal, co-founder and former CEO of Costco Wholesale Corporation, as its first trustee emeritus. Sinegal has supported the Hutch's strategic efforts since 2009. In addition to its new members, the board of trustees has appointed new leadership. Christine Gregoire, former vice chair of the board, has been appointed chair. Gregoire, currently chief executive officer of Challenge Seattle, served two terms as governor of Washington and three terms as attorney general. She has served on the Fred Hutch board of trustees since 2013. In addition to Nadella, the new Fred Hutch board members include a variety of distinguished innovators. Bryan White is the founder of Sahsen Ventures LLC, former managing director at BlackRock Alternative Advisors and co-founder of Quellos Group LLC. He serves on the board of Pomona College, is an advisor to the Institute for Protein Design at the University of Washington, is a member of the Investment Committee that oversees the University of Washington endowment and serves on the council for Chicago Booth, part of the University of Chicago Booth School of Business. Mike Clayville is vice president of worldwide commercial sales and business development at Amazon Web Services, a collection of remote-computing services that make up its cloud-computing platforms. He was inspired to launch the Clayville Foundation following the death of his first wife, Holly, from cancer in 2011 at age 46. The Clayville Foundation seeks to find new links between viruses and cancer initiation. Carl Behnke is the president of REB Enterprises. Behnke currently serves as the co-chair of the board of ambassadors for Fred Hutch and is former chairman of the Seattle Cancer Care Alliance board of directors. Mark Fleischauer is chairman of JH Kelly Holdings in southwestern Washington. He plans to bring to the board his skills as a sharp listener and behind-the-scenes catalyst.

Fred Hutchinson Cancer Research Center Wins Federal Contract for Women's Health Initiative Clinical Coordinating Center

National Institutes of Health (Department of Health and Human Services) has awarded a total current contract value: $9,954,123 -total contract value if all options are exercised: $49,785,749 federal contract on March 31 for ‘Women's Health Initiative Clinical Coordinating Center (CCC)’.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Fred Hutchinson Cancer Research Center, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at